Trial Profile

A randomized, double-blind study of the effect of Avastin plus cisplatin and gemcitabine or placebo plus cisplatin and gemcitabine on progression-free survival in treatment-naive patients with advanced or recurrent non-squamous NSCLC.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Jun 2011 New source identified and integrated (European Clinical Trials Database).
11 Feb 2010 Final analysis published in the Annals of Oncology.
30 May 2009 Final tolerability data presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO-2009).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com